Many common peptides can now not be compounded by pharmacies for human use as a result of current FDA regulatory changes. The FDA has moved lots of of these substances to Classification 2 of its Bulk Drug Substances list, citing security threats or inadequate info, creating them ineligible for compounding.will take support and help for researchers